Networks and Partners

Through the adoption of the UN Political Declaration on Non-communicable Diseases (NCDs) in 2011 Member States have recognised the critical importance of reducing the level of exposure to cancer risk factors while at the same time strengthening the capacity of individuals to make healthier choices and promoting a health-enabling environment for populations. UICC supports a number of initiatives in the cancer prevention space including:

Cancer Prevention Network

The UICC Cancer Prevention Network is a joint initiative between UICC and Cancer Council Victoria (CCV). Hosted on the International Cancer Control Partnership (ICCP) Portal, the Prevention Network builds on the expertise across the UICC membership to equip policymakers and cancer advocates in the field of health promotion and social marketing with state of the art knowledge exchange and best practices on cancer prevention, early detection and screening.

The Network’s interactive multimedia library showcases the latest effective prevention campaigns and social media marketing interventions worldwide. Join the prevention conversation and submit your campaign materials and resources to the Network’s multimedia library.

Download the Cancer Prevention Network OnePager to learn more about the Network and ways to contribute.

Building the evidence-base on E-cigarettes

Electronic Nicotine Delivery Systems (ENDS) or E-cigarettes require global regulation in order to safeguard public health. UICC will be working with its members and partners to help build and communicate the evidence-base on the risks and health impact of this emerging market.  As a starting point UICC has compiled a list of the most current position statements published on ENDs or E-cigarettes from around the globe. Download the list to learn more.

Vaccines for infection-related cancers

Latest data show that worldwide 16% of all cancer cases are caused by infections. The four main cancer-causing infectious agents are hepatitis B (HBV) and C viruses, human papillomavirus (HVP) and helicobacter pylori which together are responsible for 1.9 million cases of cancer every year, mainly liver, cervix uteri and gastric cancer.

Currently, two safe and effective vaccines can prevent infection-related cancers: liver cancer with the HBV vaccine and cervical cancer with the HPV vaccine.

UICC and Gavi, the Vaccine Alliance (Gavi) are committed in their joint advocacy efforts to accelerate the implementation of HPV and HBV immunisation into national cancer control strategies. To learn more, please download the UICC and GAVI joint Backgrounder “Revolutionising Cancer Prevention with Vaccines”.

Join the immunisation conversation online via Gavi’s blog VaccinesWork  – a blog dedicated to immunisation.

Every year on 28 July, UICC joins the World Health Organization (WHO) and partners to mark World Hepatitis Day. Globally, close to 500 million people are affected by chronic viral hepatitis and they are at risk of developing severe liver disease such as cirrhosis or liver cancer without access to care.

In March 2014, participants at the WHO's first global partners meeting on hepatitis agreed on a historic call to action to scale up the global hepatitis response. The "call to action" presses the global community for immediate and concerted action to increase access to prevention, diagnosis and treatment of viral hepatitis. To learn more about the “call to action”, please download “Call to Action to Scale Up Global Hepatitis Response”.